| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786809 | European Journal of Surgical Oncology (EJSO) | 2018 | 25 Pages |
Abstract
Adjuvant therapy was associated with improved survival in patients with resected ampullary cancer, especially with advanced stage disease. A multi-institutional randomized trial is needed to further assess the role of adjuvant therapy in ampullary adenocarcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Zhaohui Jin, Mindy L. Hartgers, Cristobal T. Sanhueza, Christopher R. Shubert, Steven R. Alberts, Mark J. Truty, Prasuna Muppa, David M. Nagorney, Thomas C. Smyrk, Mohamed Hassan, Amit Mahipal,